MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
NVIDIA
NVDA
US Stock MarketDetailed Quotes
CAMP Camp4 Therapeutics
- 4.500
- -0.450-9.09%
Close Jan 6 16:00 ET
- 4.510
- +0.010+0.22%
Post 20:01 ET
90.72MMarket Cap-1.70P/E (TTM)
5.640High4.500Low63.91KVolume5.100Open4.950Pre Close302.33KTurnover0.94%Turnover RatioLossP/E (Static)20.16MShares12.30052wk High-0.57P/B30.69MFloat Cap4.06052wk Low--Dividend TTM6.82MShs Float12.300Historical High--Div YieldTTM23.03%Amplitude4.060Historical Low4.730Avg Price1Lot Size
Camp4 Therapeutics News
Camp4 Therapeutics | 10-Q: Quarterly report
Camp4 Therapeutics | 8-K: CAMP4 Reports Third Quarter 2024 Financial Results
Camp4 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Michael P. Rubin(11.5%),Northpond Ventures II, LP(5.1%), etc.
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Amir Nashat(13.5%),Polaris Management Co. VII, L.L.C.(8.8%), etc.
Camp4 Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-10% Owner Polaris Partners GP X, L.L.C.
Camp4 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Marc Andreessen(10.9%),Benjamin Horowitz(10.9%), etc.
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Enavate Sciences GP, LLC(19.4%),Everest Aggregator, LP(19.4%)
Camp4 Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Andrew J. Schwab(15.0%),Dr. Kush Parmar(15.0%), etc.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Northpond Ventures II GP, LLC
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner AH Equity Partners Bio I, L.L.C.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Enavate Sciences GP, LLC
Camp4 Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Camp4 Therapeutics | SEC STAFF LETTER: Others
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner 5AM Partners VI, LLC
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schwab Andrew J.
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nashat Amir
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Holtzman Steven H
Camp4 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Young Richard A
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
